Clinical trial
Assay of the Immunogenicity of Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine in Africa
NCT00271479 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assay of the Immunogenicity of Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine in Africa
- Lead sponsor
- Epicentre
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- November 30, 2006
- Enrollment
- 720
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
infections, meningococcal, meningitis, meningococcic